Curis Lifesciences (NSE:CURIS) Book Value per Share: ₹58.58 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CURIS Curis Lifesciences Ltd NSE:CURIS
21 GF Score
Price ₹141.95
! 3 Warning Signs
View Full Analysis

What is Curis Lifesciences Book Value per Share?

Curis Lifesciences NSE:CURIS +3.24% 21 Book Value per Share is ₹58.58 as of Mar. 2026. GuruFocus rates NSE:CURIS with a GF Score™ of 21/100. The stock has 3 warning signs investors should review.

Curis Lifesciences's book value per share for the quarter that ended in Mar. 2026 was ₹58.58.

During the past 12 months, Curis Lifesciences's average Book Value Per Share Growth Rate was 191.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 261.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 4 years, the highest 3-Year average Book Value Per Share Growth Rate of Curis Lifesciences was 261.10% per year. The lowest was 261.10% per year. And the median was 261.10% per year.

Curis Lifesciences's current price is ₹141.95. Its book value per share for the quarter that ended in Mar. 2026 was ₹58.58. Hence, today's PB Ratio of Curis Lifesciences is 2.42.

During the past 4 years, the highest P/B Ratio of Curis Lifesciences was 7.02. The lowest was 1.54. And the median was 2.20.


Curis Lifesciences  (NSE:CURIS) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Curis Lifesciences Book Value per Share Related Terms


Curis Lifesciences Book Value per Share Historical Data

* Premium members only.

The historical data trend for Curis Lifesciences's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curis Lifesciences Book Value per Share Chart

Curis Lifesciences Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Book Value per Share
1.24 7.27 20.07 58.58

Curis Lifesciences Semi-Annual Data
Mar23 Mar24 Mar25 Mar26
Book Value per Share 1.24 7.27 20.07 58.58

NSE:CURIS vs ZTS: Book Value per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curis Lifesciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curis Lifesciences PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curis Lifesciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where Curis Lifesciences's PB Ratio falls into.


NSE:CURIS
21GF Score
Curis Lifesciences Ltd NSE:CURIS
Book Value per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curis Lifesciences Book Value per Share Calculation

Curis Lifesciences's Book Value Per Share for the fiscal year that ended in Mar. 2026 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(473.6-0.0)/8.1
=58.58

Curis Lifesciences's Book Value Per Share for the quarter that ended in Mar. 2026 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(473.6-0.0)/8.1
=58.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Frequently Asked Questions Learn more about Book Value per Share →
What does a Book Value per Share of ₹58.58 mean?
Curis Lifesciences (NSE:CURIS) has a Book Value per Share of ₹58.58 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Curis Lifesciences and its competitors.
Is Curis Lifesciences' Book Value per Share too high?
Curis Lifesciences' current Book Value per Share is ₹58.58. Overall, Curis Lifesciences has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Curis Lifesciences' Book Value per Share compare to ZTS?
Curis Lifesciences' Book Value per Share of ₹58.58 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Drug Manufacturers company?
A good Book Value per Share depends on the Drug Manufacturers industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Curis Lifesciences and its competitors. Curis Lifesciences's current Book Value per Share is ₹58.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curis Lifesciences stock overvalued right now?
Curis Lifesciences (NSE:CURIS) has a current Book Value per Share of ₹58.58. The current Book Value per Share is ₹58.58. Curis Lifesciences' overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Curis Lifesciences (NSE:CURIS), the current Book Value per Share is ₹58.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curis Lifesciences Business Description

Address PF-23, GIDC Sanand - II, Industrial Acme Pharma, Opposite Teva Pharma, Sanand, Ahmedabad, GJ, IND, 382110
Curis Lifesciences Ltd is in the business of manufacturing of pharmaceutical products. It specializes in the manufacturing of a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral liquid, and Sterile Ophthalmic Ointments. The company's business verticals are: Loan License manufacturing, Contract Manufacturing, and Direct Export. The company derives revenue from the sale of its pharmaceutical products.
21GF Score

Get the complete analysis for NSE:CURIS

Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹141.95
Price